Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Shire to Acquire Dyax for $5.9 Billion to Bolster Rare Disease Drug Business
Shire to Acquire Dyax for $5.9 Billion to Bolster Rare Disease Drug Business
Shire to Acquire Dyax for $5.9 Billion to Bolster Rare Disease Drug Business
Submitted by
admin
on November 2, 2015 - 8:10am
Source:
TheStreet.com
News Tags:
Shire
Dyax
M&A
Headline:
Shire to Acquire Dyax for $5.9 Billion to Bolster Rare Disease Drug Business
Do Not Allow Advertisers to Use My Personal information
